Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PRB Pharmaceuticals
Fountain Valley, California, United Statesprbpharmaceuticals.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
PRB Pharmaceuticals is a biopharmaceutical company that specialized in the development of broad-spectrum antiviral drugs for the treatment of respiratory viral infections. The company's primary focus was on its lead candidate, Vira 38 (PRB-101), which was investigated for its efficacy against influenza and the SARS coronavirus. PRB's research aimed to address unmet needs in infectious disease management, particularly during global health crises such as the avian flu and SARS outbreaks. Despite early clinical progress and collaborations with academic institutions, the company is currently considered inactive.
- Therapeutic areas
- Infectious Diseases
- Modalities
- Small molecule
- Industry
- Biotech
02
Partnerships
University of Hong Kong
Beyond the preview
Go deeper on PRB Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PRB Pharmaceuticals.